Imipenem Resistance among Gram Negative Bacilli

Abstract

Gram-negative bacilli are bacteria frequently implicated in human pathology. The aim of our study has consisted in detecting Gram-negative strains resistant to imipenem. The frequency of resistant strains was 0.2% for Escherichia coli, 1.4% for Proteus spp., 3.9% for Enterobacter spp. and 22.5% for Pseudomonas aeruginosa. The obtained results have demonstrated that imipenem remains an important solution for the therapy of infections produced by multidrug-resistant Gram-negative bacilli. Still, the selection of resistant strains represents a threat that needs to be in the attention of the practitioners.